PI3Kγ inhibitor 1

CAS No. 1172118-03-4

PI3Kγ inhibitor 1 ( —— )

Catalog No. M10575 CAS No. 1172118-03-4

A potent PI3Kγ inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 873 Get Quote
50MG 1782 Get Quote
100MG 2250 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    PI3Kγ inhibitor 1
  • Note
    Research use only, not for human use.
  • Brief Description
    A potent PI3Kγ inhibitor.
  • Description
    A potent PI3Kγ inhibitor.
  • Synonyms
    ——
  • Pathway
    PI3K/Akt/mTOR signaling
  • Target
    PI3K
  • Recptor
    PI3K
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    1172118-03-4
  • Formula Weight
    586.67
  • Molecular Formula
    C32H26N8O2S
  • Purity
    >98% (HPLC)
  • Solubility
    10 mM in DMSO
  • SMILES
    CC1=C2C(=CC=C1)C=C(N(C2=O)C3=CC=CC=C3C)CN4C5=NC=NC(=C5C(=N4)C6=CC7=C(C=C6)N=C(S7)NC(=O)C)N
  • Chemical Name
    Acetamide, N-[6-[4-amino-1-[[1,2-dihydro-8-methyl-2-(2-methylphenyl)-1-oxo-3-isoquinolinyl]methyl]-1H-pyrazolo[3,4-d]pyrimidin-3-yl]-2-benzothiazolyl]-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Patent WO 2014004470.
molnova catalog
related products
  • Omipalisib

    A highly potent dual inhibitor PI3K/mTOR inhibitor.

  • TGR-1202 R-enantiome...

    TGR-1202 R-enantiomer is is the less active enantiomer of TGR-1202 (Umbralisib), TGR-1202 is a potent, selective, orally available PI3Kδ inhibitor with IC50 of 22 nM.

  • GDC-0941

    A potent, selective, orally bioavailable inhibitor of class I PI3Ks with IC50 of 3/33/3/75 nM for p110α/β/γ/δ, respectively.